Related references
Note: Only part of the references are listed.Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma
Xiao-Yan Yang et al.
MOLECULES (2023)
Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways
Yiqun Zhang et al.
NATURE COMMUNICATIONS (2022)
Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma
Laura Bownes et al.
CANCERS (2022)
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
Yuhe Huang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
PP2A and cancer epigenetics: a therapeutic opportunity waiting to happen
Samantha L. Tinsley et al.
NAR CANCER (2022)
Okadaic acid promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells by inhibiting protein phosphatase 2A
Juan Kong et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2021)
PPP2R4 dysfunction promotes KRAS-mutant lung adenocarcinoma development and mediates opposite responses to MEK and mTOR inhibition
Bob Meeusen et al.
CANCER LETTERS (2021)
Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer
Mingyang Liu et al.
GASTROENTEROLOGY (2021)
Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1
Otto Kauko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer
Ashenafi Bulle et al.
TRANSLATIONAL ONCOLOGY (2020)
Machine Learning and Network Analyses Reveal Disease Subtypes of Pancreatic Cancer and their Molecular Characteristics
Musalula Sinkala et al.
SCIENTIFIC REPORTS (2020)
Selective PP2A Enhancement through Biased Heterotrimer Stabilization
Daniel Leonard et al.
CELL (2020)
Pancreatic cancer treatment: better, but a long way to go
Robert J. Torphy et al.
SURGERY TODAY (2020)
An okadaic acid fragment analogue prevents nicotine -induced resistance to cisplatin by recovering PP2A activity in non -small cell lung cancer cells
Raquel L. Arribas et al.
BIOORGANIC CHEMISTRY (2020)
Selective Inhibition of STRN3-Containing PP2A Phosphatase Restores Hippo Tumor-Suppressor Activity in Gastric Cancer
Yang Tang et al.
CANCER CELL (2020)
Targeting-PP2A-in-cancer: Combination therapies
Sahar Mazhar et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2019)
The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Active-Site Catalytic Metals in PPP5C
Brandon M. D'Arcy et al.
MOLECULAR CANCER THERAPEUTICS (2019)
The Highly Recurrent PP2A Aα-Subunit Mutation P179R Alters Protein Structure and Impairs PP2A Enzyme Function to Promote Endometrial Tumorigenesis
Sarah E. Taylor et al.
CANCER RESEARCH (2019)
Repressive role of stabilized hypoxia inducible factor 1α expression on transforming growth factor β-induced extracellular matrix production in lung cancer cells
Akira Ando et al.
CANCER SCIENCE (2019)
WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs
Yuxing Liao et al.
NUCLEIC ACIDS RESEARCH (2019)
PR55α regulatory subunit of PP2A inhibits the MOB1/LATS cascade and activates YAP in pancreatic cancer cells
Ashley L. Hein et al.
ONCOGENESIS (2019)
Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Adenocarcinoma
Brittany L. Allen-Petersen et al.
CANCER RESEARCH (2019)
Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes
Lan Zhao et al.
BMC CANCER (2018)
Small-Molecule Activators of Protein Phosphatase 2A for the Treatment of Castration-Resistant Prostate Cancer
Kimberly McClinch et al.
CANCER RESEARCH (2018)
Integrated Genomic and Immunophenotypic Classification of Pancreatic Cancer Reveals Three Distinct Subtypes with Prognostic/Predictive Significance
Martin Wartenberg et al.
CLINICAL CANCER RESEARCH (2018)
Tumor suppressive protein phosphatases in human cancer: Emerging targets for therapeutic intervention and tumor stratification
Bob Meeusen et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Non-genomic mechanisms of protein phosphatase 2A (PP2A) regulation in cancer
Otto Kauko et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Therapeutic targeting of PP2A
Caitlin M. O'Connor et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Polyphyllin I inhibits invasion and epithelial-mesenchymal transition via CIP2A/PP2A/ERK signaling in prostate cancer
Xuewen Liu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells
Otto Kauko et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Polyphyllin I inhibits growth and invasion of cisplatin-resistant gastric cancer cells by partially inhibiting CIP2A/PP2A/Akt signaling axis
Yunfei Zhang et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2018)
The combination of cantharidin and antiangiogenic therapeutics presents additive antitumor effects against pancreatic cancer
Meng-Dan Xu et al.
ONCOGENESIS (2018)
Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth
Jaya Sangodkar et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
SET contributes to the epithelial-mesenchymal transition of pancreatic cancer
Hardik R. Mody et al.
Oncotarget (2017)
PP2A Inactivation Mediated by PPP2R4 Haploinsufficiency Promotes Cancer Development
Ward Sents et al.
CANCER RESEARCH (2017)
Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56
Jiao Wang et al.
EMBO REPORTS (2017)
Overexpression of CIP2A promotes bladder cancer progression by regulating EMT
X. Pang et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2016)
Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma
Rekin's Janky et al.
BMC CANCER (2016)
PR55α Subunit of Protein Phosphatase 2A Supports the Tumorigenic and Metastatic Potential of Pancreatic Cancer Cells by Sustaining Hyperactive Oncogenic Signaling
Ashley L. Hein et al.
CANCER RESEARCH (2016)
Potential anti-tumor effects of FTY720 associated with PP2A activation: a brief review
Ion Cristobal et al.
CURRENT MEDICAL RESEARCH AND OPINION (2016)
PP2A binds to the LIM domains of lipoma-preferred partner through its PR130/B subunit to regulate cell adhesion and migration
Veerle Janssens et al.
JOURNAL OF CELL SCIENCE (2016)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
From bench to bedside a comprehensive review of pancreatic cancer immunotherapy
Paul R. Kunk et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Targeting stromal microenvironment in pancreatic ductal adenocarcinoma: controversies and promises
Lin Mei et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
M. Ducreux et al.
ANNALS OF ONCOLOGY (2015)
Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer
Wenwen Chien et al.
MOLECULAR ONCOLOGY (2015)
Overexpression of CIP2A in clear cell renal cell carcinoma promotes cellular epithelial-mesenchymal transition and is associated with poor prognosis
Qizhen Tang et al.
ONCOLOGY REPORTS (2015)
Biology of Hypoxia
Paul N. Span et al.
SEMINARS IN NUCLEAR MEDICINE (2015)
Cantharidin represses invasion of pancreatic cancer cells through accelerated degradation of MMP2 mRNA
Meng Shen et al.
SCIENTIFIC REPORTS (2015)
Label-free quantitative phosphoproteomics with novel pairwise abundance normalization reveals synergistic RAS and CIP2A signaling
Otto Kauko et al.
SCIENTIFIC REPORTS (2015)
Epithelial Mesenchymal Transition: a double-edged sword
Guislaine Barriere et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2015)
The RhoGEF GEF-H1 Is Required for Oncogenic RAS Signaling via KSR-1
Jane Cullis et al.
CANCER CELL (2014)
STRIPAK complexes: Structure, biological function, and involvement in human diseases
Juyeon Hwang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia
Alejandro Gutierrez et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells
Paolo Neviani et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
CIP2A expression is associated with altered expression of epithelial-mesenchymal transition markers and predictive of poor prognosis in pancreatic ductal adenocarcinoma
Lei Wang et al.
TUMOR BIOLOGY (2013)
Characterization of a cell culture model for clinically aggressive hepatocellular carcinoma induced by chronic hypoxia
Hannah van Malensteina et al.
CANCER LETTERS (2012)
The Role and Therapeutic Potential of Ser/Thr Phosphatase PP2A in Apoptotic Signalling Networks in Human Cancer Cells
V. Janssens et al.
CURRENT MOLECULAR MEDICINE (2012)
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Eric A. Collisson et al.
NATURE MEDICINE (2011)
Glycogene Expression Alterations Associated with Pancreatic Cancer Epithelial-Mesenchymal Transition in Complementary Model Systems
Kevin A. Maupin et al.
PLOS ONE (2010)
Epithelial-Mesenchymal Transition in Pancreatic Carcinoma
Harald J. Maier et al.
Cancers (2010)
Protein phosphatase 2A regulatory subunits and cancer
Pieter J. A. Eichhorn et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2009)
PME-1 Protects Extracellular Signal-Regulated Kinase Pathway Activity from Protein Phosphatase 2A-Mediated Inactivation in Human Malignant Glioma
Pietri Puustinen et al.
CANCER RESEARCH (2009)
Two highly related regulatory subunits of PP2A exert opposite effects on TGF-β/Activin/Nodal signalling
Julie Batut et al.
DEVELOPMENT (2008)
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia
Paolo Neviani et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The tumor suppressor PP2A Aβ regulates the RaIA GTPase
Anna A. Sablina et al.
CELL (2007)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
VK Mootha et al.
NATURE GENETICS (2003)
Share Paper
